GlassScriptPhysician profile
James D Romano
NPI 1568438620
$464.01
in general payments reported to CMS, 2019-2025
12 companies · $98.77 in 2025
The $98.77 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.38 · 2022: $81.39 · 2023: $124 · 2024: $118 · 2025: $98.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $99.05 | 2023-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $84.78 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $46.77 | 2023-2025 | |
| Exact Sciences Corporation | $42.40 | 2023 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $36.50 | 2022-2023 | |
| Glaxosmithkline, LLC. | $28.08 | 2022-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.32 | 2022 | |
| Myovant Sciences INC. | $25.40 | 2021 | |
| Inspire Medical Systems, INC. | $22.32 | 2024 | Inspire |
| Abbott Laboratories | $22.20 | 2022 | |
| Getinge USA Sales, LLC | $15.98 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.21 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Romano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.